Details of the Drug

General Information of Drug (ID: DMTFR5B)

Drug Name
NLS-1
Indication
Disease Entry ICD 11 Status REF
Attention deficit hyperactivity disorder 6A05.Z Phase 2 [1]
Cross-matching ID
TTD ID
D0Y0VC

References

1 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)